{"items":[{"htmlTitle":"<b>COVID<\/b>-<b>19<\/b>: consider cytokine storm syndromes and immunosuppression","displayLink":"[PDF] thelancet.com","link":"https:\/\/www.thelancet.com\/journals\/lancet\/article\/PIIS0140-6736(20)30628-0\/fulltext","htmlSnippet":"As of March 12, 2020, coronavirus disease 2019 (<b>COVID<\/b>-<b>19<\/b>) has been con firmed in 125 <br>048 people worldwide, carrying a mortality of approximately 3\u00b7 7%, 1 compared with a <br>mortality rate of less than 1% from influenza. There is an urgent need for effective treatment\u00a0\u2026","citedBy":"Cited by 341"},{"htmlTitle":"Presumed asymptomatic carrier transmission of <b>COVID<\/b>-<b>19<\/b>","displayLink":"[HTML] jamanetwork.com","link":"https:\/\/jamanetwork.com\/journals\/jama\/article-abstract\/2762028","htmlSnippet":"Methods| In January 2020, we enrolled a familial cluster of 5 patients with fever and <br>respiratory symptoms who were admitted to the Fifth People's Hospital of Anyang, Anyang, <br>China, and 1 asymptomatic family member. This study was approved by the local\u00a0\u2026","citedBy":"Cited by 492"},{"htmlTitle":"The reproductive number of <b>COVID<\/b>-<b>19 <\/b>is higher compared to SARS coronavirus","displayLink":"[HTML] oup.com","link":"https:\/\/academic.oup.com\/jtm\/advance-article\/doi\/10.1093\/jtm\/taaa021\/5735319?fbclid=IwAR3uhg3X7nS4A-ax2Ah-p_Al92EktHFIUj5CCBmCDSpbyft9UKEOtb4x4BI","htmlSnippet":"\u00a9 International Society of Travel Medicine 2020. This is an Open Access article distributed under <br>\nthe terms of the Creative Commons Attribution Non-Commercial License <br>\n(http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/), which permits non-commercial re-use\u00a0\u2026","citedBy":"Cited by 332"},{"htmlTitle":"<b>COVID<\/b>-<b>19 <\/b>and Italy: what next?","displayLink":"[HTML] thelancet.com","link":"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0140673620306279","htmlSnippet":"The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already <br>taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global <br>response to prepare health systems worldwide is imperative. Although containment\u00a0\u2026","citedBy":"Cited by 333"},{"htmlTitle":"An interactive web-based dashboard to track <b>COVID<\/b>-<b>19 <\/b>in real time","displayLink":"[PDF] thelancet.com","link":"https:\/\/www.thelancet.com\/journals\/laninf\/article\/PIIS1473-3099(20)30120-1\/fulltext","htmlSnippet":"In December, 2019, a local outbreak of pneumonia of initially unknown cause was detected <br>in Wuhan (Hubei, China), and was quickly determined to be caused by a novel coronavirus, <br>1 namely severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The outbreak\u00a0\u2026","citedBy":"Cited by 379"},{"htmlTitle":"Coronavirus disease 2019 (<b>COVID<\/b>-<b>19<\/b>): situation report, 72","displayLink":"[PDF] who.int","link":"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331685\/nCoVsitrep01Apr2020-eng.pdf","htmlSnippet":"\u2022 WHO has released a scientific brief on the off-label use of medicines for <b>COVID<\/b>-<b>19<\/b>. A <br>number of medicines have been suggested as potential investigational therapies, many of <br>which are now being or will soon be studied in clinical trials, including the SOLIDARITY trial\u00a0\u2026","citedBy":"Cited by 238"},{"htmlTitle":"Severe outcomes among patients with coronavirus disease 2019 (<b>COVID<\/b>-<b>19<\/b>)\u2014United States, February 12\u2013March 16, 2020","displayLink":"[PDF] ecie.com.ar","link":"http:\/\/www.ecie.com.ar\/images\/paginas\/COVID-19\/4MMWR-Severe_Outcomes_Among_Patients_with_Coronavirus_Disease_2019_COVID-19-United_States_February_12-March_16_2020.pdf","htmlSnippet":"Discussion Since February 12, 4,226 COVID-19 cases were reported in the United States; <br>31% of cases, 45% of hospitalizations, 53% of ICU admissions, and 80% of deaths occurred <br>among adults aged\u2265 65 years with the highest percentage of severe outcomes among\u00a0\u2026","citedBy":"Cited by 120"},{"htmlTitle":"Pathological findings of <b>COVID<\/b>-<b>19 <\/b>associated with acute respiratory distress syndrome","displayLink":"[HTML] thelancet.com","link":"https:\/\/www.thelancet.com\/journals\/lanres\/article\/PIIS2213-2600(20)30076-X\/fulltext?rss=yes&utm_campaign=update-lanres&utm_source=hs_email&utm_medium=email&utm_content=83570178&_hsenc=p2ANqtz-9uESUXj_Lm4iXDmvI7dkxjM6zR338P5y63h6v-10exFeWJ3NmnEemsd0SL_ftH9EkPEZ3SiWrzL7vAIGVMdFVtzj32qQ&_hsmi=83570178","htmlSnippet":"which has subsequently affected 26 countries worldwide. In general, <b>COVID<\/b>-<b>19 <\/b>is an acute <br>resolved disease but it can also be deadly, with a 2% case fatality rate. Severe disease <br>onset might result in death due to massive alveolar damage and progressive respiratory\u00a0\u2026","citedBy":"Cited by 567"},{"htmlTitle":"Coronavirus disease 2019 (<b>COVID<\/b>-<b>19<\/b>): situation report, 67","displayLink":"[PDF] who.int","link":"https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331613\/nCoVsitrep27Mar2020-eng.pdf","htmlSnippet":"\u2022 OpenWHO celebrates 1 million enrollments today. Seventy percent of the total enrollments <br>are on <b>COVID<\/b>-<b>19 <\/b>resources, reflecting the critical role the platform is playing in supporting <br>the response to the pandemic. On 25 March, a new course was launched describing how to\u00a0\u2026","citedBy":"Cited by 205"},{"htmlTitle":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of <b>COVID<\/b>-<b>19 <\/b>associated pneumonia in clinical studies","displayLink":"[PDF] jst.go.jp","link":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/advpub\/0\/advpub_2020.01047\/_article\/-char\/ja\/","htmlSnippet":"\u6284\u9332 The coronavirus disease 2019 (<b>COVID<\/b>-<b>19<\/b>) virus is spreading rapidly, and scientists are <br>endeavoring to discover drugs for its efficacious treatment in China. Chloroquine phosphate, <br>an old drug for treatment of malaria, is shown to have apparent efficacy and acceptable\u00a0\u2026","citedBy":"Cited by 436"}]}